The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Targeting the “Cytokine Storm” for Therapeutic Benefit
Open accessAbstract
Inflammation is the body's first line of defense against infection or injury, responding to challenges by activating innate and adaptive responses. Microbes have evolved a diverse range of strategies to avoid triggering inflammatory responses. However, some pathogens, such as the influenza virus and the Gram-negative bacterium Francisella tularensis, do trigger life-threatening “cytokine storms” in the host which can result in significant pathology and ultimately death. For these diseases, it has been proposed that downregulating inflammatory immune responses may improve outcome. We review some of the current candidates for treatment of cytokine storms which may prove useful in the clinic in the future and compare them to more traditional therapeutic candidates that target the pathogen rather than the host response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187 · cited 1×
“16 It has been suggested that one Treg cell can influence numerous surrounding cells 486 [102].”
BackgroundFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
IL-10: The Master Regulator of Immunity to Infection
Couper, K. N., Blount, D. G., & Riley, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5771 · Cited by 2,223
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Fleming, A. (1929) · PubMed Central · Cited by 1,647
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · cited 1×
“They elicit their effects via a range of mechanisms and are able to 502 reduce neutrophil infiltration [106], increase the uptake of apoptotic neutrophils [107] 503 and increase cellular exit via the lymphatic system.”
BackgroundResolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., & Bowcock, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11679 · Cited by 940
Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens
Finlay, B. B., & McFadden, G. (2006) · Cell · doi:10.1016/j.cell.2006.01.034 · Cited by 904
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
Regulatory T cells and mechanisms of immune system control
O'Garra, A., & Vieira, P. (2004) · Nature Medicine · doi:10.1038/nm0804-801 · Cited by 810
Band Horwitz, S. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90048-b · Cited by 740
Molecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins
Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., & Serhan, C. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4345 · Cited by 699
Chemokines in pathology and medicine
Baggiolini, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00867.x · Cited by 677
Chemokine receptors: Gateways to inflammation and infection
Premack, B. A., & Schall, T. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1174 · Cited by 630
Perrone, L. A., Plowden, J. K., García-Sastre, A., Katz, J. M., & Tumpey, T. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000115 · Cited by 623
Fleming, A. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.1.129 · Cited by 612
Structure, Function, and Inhibition of Chemokines
Fernandez, E. J., & Lolis, E. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091901.115838 · Cited by 609
The chemokine and chemokine receptor superfamilies and their molecular evolution.
Zlotnik, A., Yoshie, O., & Nomiyama, H. (2006) · Genome biology · doi:10.1186/gb-2006-7-12-243 · Cited by 604
Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., & Serhan, C. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409271102 · Cited by 590
The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells
Shevach, E. M., DiPaolo, R. A., Andersson, J., Zhao, D., Stephens, G. L., & Thornton, A. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00415.x · Cited by 590
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management
Piret, J., & Boivin, G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00615-10 · Cited by 558
Resolvin D1 and Its Aspirin-triggered 17R Epimer
Sun, Y.-P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., & Serhan, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609212200 · Cited by 537
A calculated response: control of inflammation by the innate immune system
Barton, G. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34431 · Cited by 532 · cited 1×
“74 Intracellular PRRs, notably the Nod-like receptors (NLRs), are found in the cytosol 75 for the detection of intracellular pathogens [4].”
BackgroundTularaemia: bioterrorism defence renews interest in Francisella tularensis
Oyston, P. C. F., Sjöstedt, A. B., & Titball, R. W. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1045 · Cited by 496
Self-citationBacteriophages as potential new therapeutics to replace or supplement antibiotics
Kutateladze, M., & Adamia, R. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.08.001 · Cited by 483
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426
Developmental regulation of Foxp3 expression during ontogeny
Fontenot, J. D., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050784 · Cited by 417
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Brusko, T. M., Putnam, A. L., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00637.x · Cited by 374
Zimmerman, G. A., McIntyre, T. M., Prescott, S. M., & Stafforini, D. M. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205001-00020 · Cited by 358
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings
(1989) · Journal of Critical Care · doi:10.1016/0883-9441(89)90142-1 · Cited by 357
Pavlov, V. A., Ochani, M., Yang, L.-H., Gallowitsch-Puerta, M., Ochani, K., Lin, X., Levi, J., Parrish, W. R., Rosas-Ballina, M., Czura, C. J., et al. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000259381.56526.96 · Cited by 353
Akdis, M., Blaser, K., & Akdis, C. A. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.004 · Cited by 351
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 342
Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury
Duffield, J. S., Hong, S., Vaidya, V. S., Lu, Y., Fredman, G., Serhan, C. N., & Bonventre, J. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5902 · Cited by 334
Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., & Klinman, D. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2291 · Cited by 314
Zheng, B.-J., Chan, K.-W., Lin, Y.-P., Zhao, G.-Y., Chan, C., Zhang, H.-J., Chen, H.-L., Wong, S. S. Y., Lau, S. K. P., Woo, P. C. Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711942105 · Cited by 302
Yoshikawa, H., Kurokawa, M., Ozaki, N., Nara, K., Atou, K., Takada, E., Kamochi, H., & Suzuki, N. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03169.x · Cited by 289
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
Strieter, R. M., Polverini, P. J., Arenberg, D. A., Walz, A., Opdenakker, G., Van Damme, J., & Kunkel, S. L. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.752 · Cited by 250
Kem, W. R. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00211-4 · Cited by 231
Metabolism and antiviral activity of ribavirin
Parker, W. B. (2005) · Virus Research · doi:10.1016/j.virusres.2004.11.006 · Cited by 227
Matsunaga, K., Klein, T. W., Friedman, H., & Yamamoto, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6518 · Cited by 225
Novel approaches to developing new antibiotics for bacterial infections
Coates, A. R. M., & Hu, Y. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707432 · Cited by 218
Bennett, C. L., & Ochs, H. D. (2001) · Current Opinion in Pediatrics · doi:10.1097/00008480-200112000-00007 · Cited by 202
Wang, S., Le, T. Q., Kurihara, N., Chida, J., Cisse, Y., Yano, M., & Kido, H. (2010) · The Journal of Infectious Diseases · doi:10.1086/656044 · Cited by 195
Anti‐inflammatory cytokines in asthma and allergy: interleukin‐10, interleukin‐12, interferon‐γ
Chung, F. (2001) · Mediators of Inflammation · doi:10.1080/09629350120054518 · Cited by 193
Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu4
Bosio, C. M., Bielefeldt-Ohmann, H., & Belisle, J. T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4538 · Cited by 190
Role of interleukin-8 in neutrophil signaling
Zeilhofer, H. U., & Schorr, W. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200005000-00009 · Cited by 179
Opal, S. M., Laterre, P., Abraham, E. H., François, B., Wittebole, X., Lowry, S., Dhainaut, J.-F., Warren, B., Dugernier, T., Lopez, A., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000108867.87890.6d · Cited by 147
Cameron, C. E., & Castro, C. D. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200112000-00015 · Cited by 147
The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses
Yost, C. C., Weyrich, A. S., & Zimmerman, G. A. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.011 · Cited by 146
Role of Endothelial Chemokines and Their Receptors during Inflammation
Speyer, C. L., & Ward, P. A. (2011) · Journal of Investigative Surgery · doi:10.3109/08941939.2010.521232 · Cited by 145
Crown, J. P., Jakubowski, A. A., Kemeny, N. E., Gordon, M. S., Gasparetto, C., Wong, G. G., Sheridan, C., Toner, G. C., Meisenberg, B., & Botet, J. F. (1991) · Blood · doi:10.1182/blood.v78.6.1420.1420 · Cited by 142
Regulatory T cells in human disease and their potential for therapeutic manipulation
Taams, L. S., Palmer, D. B., Akbar, A. N., Robinson, D. S., Brown, Z., & Hawrylowicz, C. M. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02348.x · Cited by 136
Lee, S. M. Y., Cheung, C. Y., Nicholls, J. M., Hui, K. P. Y., Leung, C. Y. H., Uiprasertkul, M., Tipoe, G. L., Lau, Y., Poon, L. L. M., Ip, N. Y., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590499 · Cited by 132
Antibody-Based Therapies for Emerging Infectious Diseases
Casadevall, A. (1996) · Emerging infectious diseases · doi:10.3201/eid0203.960306 · Cited by 123
Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection
Souza, D. G., Fagundes, C. T., Sousa, L. P., Amaral, F. A., de Souza, R. S. C., Souza, A. L., Kroon, E. G., Sachs, D., Cunha, F. Q., Bukin, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906467106 · Cited by 118
CD38/CD19: a lipid raft–dependent signaling complex in human B cells
Deaglio, S., Vaisitti, T., Billington, R. A., Bergui, L., Omedè, P., Genazzani, A. A., & Malavasi, F. (2007) · Blood · doi:10.1182/blood-2006-12-061812 · Cited by 118
Mares, C. A., Ojeda, S. S., Morris, E. G., Li, Q., & Teale, J. M. (2008) · Infection and Immunity · doi:10.1128/iai.00215-08 · Cited by 116
Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor
Nakano, Y., Kasahara, T., Mukaida, N., Ko, Y. C., Nakano, M., & Matsushima, K. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.377-383.1994 · Cited by 104
Ribavirin Can Be Mutagenic for Arenaviruses
Moreno, H., Gallego, I., Sevilla, N., de la Torre, J. C., Domingo, E., & Martı́n, V. (2011) · Journal of Virology · doi:10.1128/jvi.00614-11 · Cited by 101
Lin, K. L., Sweeney, S., Kang, B. D., Ramsburg, E. A., & Gunn, M. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001002 · Cited by 94
Kox, M., van Velzen, J. F., Pompe, J. C., Hoedemaekers, C., van der Hoeven, J. G., & Pickkers, P. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.096 · Cited by 92
Camoglio, L., Velde, A. A. T., Boer, A. M. T., ten Kate, F. J. W., Köpf, M., & van Deventer, S. J. H. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200005)30:5<1410::aid-immu1410>3.0.co;2-l · Cited by 85
Schuster, D. P., Metzler, M. H., Opal, S. M., Lowry, S., BALK, R. A., Abraham, E. H., Levy, H. A., Slotman, G. J., Coyne, E., Souza, S., et al. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063267.79824.db · Cited by 84
Kox, M., Pompe, J. C., de Gouberville, M. C. G., van der Hoeven, J. G., Hoedemaekers, C., & Pickkers, P. (2011) · Shock · doi:10.1097/shk.0b013e3182168d56 · Cited by 84
VAN WESTERLOO, D. J., GIEBELEN, I. A. J., MEIJERS, J. C. M., DAALHUISEN, J., DE VOS, A. F., LEVI, M., & VAN DER POLL, T. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02112.x · Cited by 84
Inhibition of in vivo tumor growth by the beta chemokine, TCA3.
Laning, J. C., Kawasaki, H., Tanaka, E., Luo, Y., & Dorf, M. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4625 · Cited by 82
Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
Carey, M. A., Bradbury, J. A., Rebolloso, Y. D., Graves, J. P., Zeldin, D. C., & Germolec, D. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011610 · Cited by 77
BLOCKING PROSTAGLANDIN E2 AFTER TRAUMA ATTENUATES PRO-INFLAMMATORY CYTOKINES AND IMPROVES SURVIVAL
Strong, V. E. M., Mackrell, P. J., Concannon, E. M., Naama, H. A., Schaefer, P. A., Shaftan, G. W., Stapleton, P. P., & Daly, J. M. (2000) · Shock · doi:10.1097/00024382-200014030-00023 · Cited by 71
THE PROTECTIVE EFFECT OF THE CHOLINERGIC ANTI-INFLAMMATORY PATHWAY AGAINST SEPTIC SHOCK IN RATS
Song, X., Li, J.-G., Wang, Y., Hu, Z., Zhou, Q., Du, Z., & Jia, B. (2008) · Shock · doi:10.1097/shk.0b013e31816d5e49 · Cited by 70
Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain
Sharma, J., Mares, C. A., Li, Q., Morris, E. G., & Teale, J. M. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.03.007 · Cited by 66
Extensively Drug-Resistant Tuberculosis: A New Face to an Old Pathogen
Shenoi, S., & Friedland, G. H. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.053107.103955 · Cited by 65
Gomes, R. N., Bozza, F. A., Amancio, R. T., Japiassú, A. M., Vianna, R. C. S., Larangeira, A. P., Gouvêa, J. M., Bastos, M. S., Zimmerman, G. A., Stafforini, D. M., et al. (2006) · Shock · doi:10.1097/01.shk.0000209562.00070.1a · Cited by 62
Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection
Yoshikai, Y. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200106000-00003 · Cited by 62
Chemokines as novel therapeutic targets in inflammatory diseases
Ajuebor, M. N., Swain, M. G., & Perretti, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00854-7 · Cited by 57
Cheng, X., Lü, J., Wu, C., Yi, L., Xie, X., Shi, X., Fang, S.-S., Zan, H., Kung, H., & He, M. (2010) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2010.11.004 · Cited by 57
The development of anti-inflammatory drugs for infectious diseases.
Garcia, C. C., Guabiraba, R., Soriani, F. M., & Teixeira, M. M. (2010) · PubMed · Cited by 54
Lauder, S. N., Taylor, P. R., Clark, S., Evans, R. L., Hindley, J. P., Smart, K., Leach, H., Kidd, E. J., Broadley, K. J., Jones, S. A., et al. (2011) · Thorax · doi:10.1136/thx.2010.150318 · Cited by 51
Reckless, J., Tatalick, L. M., & Grainger, D. J. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01228.x · Cited by 49
TLRs, NLRs and RLRs: Innate sensors and their impact on allergic diseases – A current view
Heine, H. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.04.010 · Cited by 33
Karpus, W. J., Fife, B. T., & Kennedy, K. J. (2003) · Methods · doi:10.1016/s1046-2023(02)00360-2 · Cited by 28
Totally drug‐resistant tuberculosis in India: Who let the djinn out?
Udwadia, Z. F. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02192.x · Cited by 22
Villa, P., Meazza, C., Sironi, M., Bianchi, M., Ulrich, P. C., Botchkina, G. I., Tracey, K. J., & Ghezzi, P. (1997) · Journal of Endotoxin Research · doi:10.1177/096805199700400305 · Cited by 18
Role for interleukin‐1 in the pathogenesis of hypersensitivity diseases
Dinarello, C. A., & Endres, S. (1989) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240390303 · Cited by 15
Lilić, D. (2009) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2009.01.013 · Cited by 13
First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1
de Castro, I., Guzmán, M. G., García–Álvarez, M., & Resino, S. (2010) · Critical Care · doi:10.1186/cc8846 · Cited by 12
Kalden, J. R. (1987) · European Heart Journal · doi:10.1093/eurheartj/8.suppl_j.1 · Cited by 9
Progress on novel immunomodulatory agents for HIV-1 infection and other infectious diseases
Masihi, K. N. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.6.867 · Cited by 4
Cited by
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Jose, R. J., & Manuel, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30216-2 · Cited by 1,240
Activation and evasion of type I interferon responses by SARS-CoV-2
Lei, X., Dong, X., Ma, R., Wang, W., Xiao, X., Tian, Z., Wang, C., Wang, Y., Li, L., Ren, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17665-9 · Cited by 980
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhou, Z., Ren, L., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.017 · Cited by 938
Yang, Y., Shen, C., Li, J., Yuan, J., Wei, J., Huang, F., Wang, F., Li, G., Li, Y., Xing, L., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.027 · Cited by 872
Metadata
- Authors
- D'Elia, R. V., Harrison, K., Oyston, P. C., Lukaszewski, R. A., & Clark, G. C.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2013-01-02
- Volume
- 20
- Issue
- 3
- Pages
- 319-327
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2147453764
- Cited by
- 324
- References
- 103
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.